- Fourth-quarter net sales increased 2.9% year-over-year to $1.01 billion; organic sales moved up1.9%
- Net income, including special items, was $67 million or $0.32 per share in Q4, vs. a loss of $15 million or $0.07 per share a year earlier
- On an adjusted basis, the company reported earnings of $0.44 per share, down from the $0.46 per share it reported a year earlier
- For fiscal 2024, the company expects organic sales to be flat to up 1.5%; adjusted EPS is expected to be between $2.00 and $2.10
- The board of directors approved a 14% increase in the company’s quarterly dividend rate, from the previous rate of $0.14 per share
Market News
Earnings Summary: Dentsply Sirona reports higher sales for Q4 2023
Dentsply Sirona Inc. (NASDAQ: XRAY), a leading manufacturer of professional dental products and technologies, reported fourth-quarter 2023 financial results, reporting an increase in net sales. Fourth-quarter net sales increased 2.9% year-over-year to $1.01 billion; organic sales moved up1.9% Net income, including special items, was $67 million or $0.32 per share in Q4, vs. a loss […]
“Dentsply Sirona Inc. (NASDAQ: XRAY), a leading manufacturer of professional dental products and technologies, reported fourth-quarter 2023 financial results, reporting an increase in net sales. Fourth-quarter net sales increased 2.9% year-over-year to $1.01 billion; organic sales moved up1.9% Net income, including special items, was $67 million or $0.32 per share in Q4, vs. a loss […]
· February 29, 2024
Dentsply Sirona Inc. (NASDAQ: XRAY), a leading manufacturer of professional dental products and technologies, reported fourth-quarter 2023 financial results, reporting an increase in net sales.